BORDONI, Valentina
BORDONI, Valentina
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs)
2021-01-01 Riu, F.; Sanna, L.; Ibba, R.; Piras, S.; Bordoni, V.; Scorciapino, M. A.; Lai, M.; Sestito, S.; Bagella, L.; Carta, A.
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment
2022-01-01 Marchesi, I.; Fais, M.; Fiorentino, F. P.; Bordoni, V.; Sanna, L.; Zoroddu, S.; Bagella, L.
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis
2021-01-01 Virdis, Patrizia; Migheli, Rossana; Bordoni, Valentina; Fiorentino, Francesco Paolo; Sanna, Luca; Marchesi, Irene; Pintore, Giorgio; Galleri, Grazia; Muroni, Maria Rosaria; Bagella, Luigi; Fozza, Claudio; De Miglio, Maria Rosaria; Podda, Luigi
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs)
2022-01-01 Riu, F; Ibba, R; Zoroddu, S; Sestito, S; Lai, M; Piras, S; Sanna, L; Bordoni, V; Bagella, L; Carta, A
Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors
2024-01-01 Zoroddu, S.; Sanna, L.; Bordoni, V.; Weidong, L.; Gadau, S. D.; Carta, A.; Kelvin, D. J.; Bagella, L.
Immune Profiling of Polysaccharide Submicron Vesicles
2018-01-01 Toma, Chiara C.; Aloisi, Alessandra; Bordoni, Valentina; Di Corato, Riccardo; Rauner, Martina; Cuniberti, Gianaurelio; Delogu, Lucia G.; Rinaldi, Rosaria
Long noncoding RNA SYISL: the crucial interaction with EZH2 in skeletal muscle differentiation and disorders
2019-01-01 Bordoni, Valentina; Bagella, Luigi
Nanotechnology applications: from bone regeneration to cancer therapy
2020-01-01 Bordoni, Valentina
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity
2022-01-01 Zoroddu, S.; Corona, P.; Sanna, L.; Borghi, F.; Bordoni, V.; Asproni, B.; Pinna, G. A.; Bagella, L.; Murineddu, G.
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines
2023-01-01 Zoroddu, Stefano; Sanna, Luca; Bordoni, Valentina; Lyu, Weidong; Murineddu, Gabriele; Pinna, Gerard A; Forcales, Sonia Vanina; Sala, Arturo; Kelvin, David J; Bagella, Luigi
Silver nanoparticles derived by artemisia arborescens reveal anticancer and apoptosis-inducing effects
2021-01-01 Bordoni, V.; Sanna, L.; Lyu, W.; Avitabile, E.; Zoroddu, S.; Medici, S.; Kelvin, D. J.; Bagella, L.
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties
2020-01-01 Weidong, L.; Sanna, L.; Bordoni, V.; Tiansheng, Z.; Chengxun, L.; Murineddu, G.; Pinna, G. A.; Kelvin, D. J.; Bagella, L.
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines
2019-01-01 Sanna, L.; Piredda, R.; Marchesi, I.; Bordoni, V.; Forcales, S. V.; Calvisi, D. F.; Bagella, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) | 1-gen-2021 | Riu, F.; Sanna, L.; Ibba, R.; Piras, S.; Bordoni, V.; Scorciapino, M. A.; Lai, M.; Sestito, S.; Bagella, L.; Carta, A. | |
| Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment | 1-gen-2022 | Marchesi, I.; Fais, M.; Fiorentino, F. P.; Bordoni, V.; Sanna, L.; Zoroddu, S.; Bagella, L. | |
| Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis | 1-gen-2021 | Virdis, Patrizia; Migheli, Rossana; Bordoni, Valentina; Fiorentino, Francesco Paolo; Sanna, Luca; Marchesi, Irene; Pintore, Giorgio; Galleri, Grazia; Muroni, Maria Rosaria; Bagella, Luigi; Fozza, Claudio; De Miglio, Maria Rosaria; Podda, Luigi | |
| Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) | 1-gen-2022 | Riu, F; Ibba, R; Zoroddu, S; Sestito, S; Lai, M; Piras, S; Sanna, L; Bordoni, V; Bagella, L; Carta, A | |
| Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors | 1-gen-2024 | Zoroddu, S.; Sanna, L.; Bordoni, V.; Weidong, L.; Gadau, S. D.; Carta, A.; Kelvin, D. J.; Bagella, L. | |
| Immune Profiling of Polysaccharide Submicron Vesicles | 1-gen-2018 | Toma, Chiara C.; Aloisi, Alessandra; Bordoni, Valentina; Di Corato, Riccardo; Rauner, Martina; Cuniberti, Gianaurelio; Delogu, Lucia G.; Rinaldi, Rosaria | |
| Long noncoding RNA SYISL: the crucial interaction with EZH2 in skeletal muscle differentiation and disorders | 1-gen-2019 | Bordoni, Valentina; Bagella, Luigi | |
| Nanotechnology applications: from bone regeneration to cancer therapy | 1-gen-2020 | Bordoni, Valentina | |
| Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity | 1-gen-2022 | Zoroddu, S.; Corona, P.; Sanna, L.; Borghi, F.; Bordoni, V.; Asproni, B.; Pinna, G. A.; Bagella, L.; Murineddu, G. | |
| RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines | 1-gen-2023 | Zoroddu, Stefano; Sanna, Luca; Bordoni, Valentina; Lyu, Weidong; Murineddu, Gabriele; Pinna, Gerard A; Forcales, Sonia Vanina; Sala, Arturo; Kelvin, David J; Bagella, Luigi | |
| Silver nanoparticles derived by artemisia arborescens reveal anticancer and apoptosis-inducing effects | 1-gen-2021 | Bordoni, V.; Sanna, L.; Lyu, W.; Avitabile, E.; Zoroddu, S.; Medici, S.; Kelvin, D. J.; Bagella, L. | |
| Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties | 1-gen-2020 | Weidong, L.; Sanna, L.; Bordoni, V.; Tiansheng, Z.; Chengxun, L.; Murineddu, G.; Pinna, G. A.; Kelvin, D. J.; Bagella, L. | |
| Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines | 1-gen-2019 | Sanna, L.; Piredda, R.; Marchesi, I.; Bordoni, V.; Forcales, S. V.; Calvisi, D. F.; Bagella, L. |